Kohta Takahashi
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Biological and Pathological Roles of Ganglioside Sialidases.
Journal: Progress in molecular biology and translational science
Published: May 12, 2018
Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
Journal: Experimental neurology
Published: July 13, 2017
Sialidase NEU3 defines invasive potential of human glioblastoma cells by regulating calpain-mediated proteolysis of focal adhesion proteins.
Journal: Biochimica et biophysica acta. General subjects
Published: February 03, 2017
Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1.
Journal: PloS one
Published: June 03, 2015
Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum.
Journal: Cancer science
Published: December 09, 2014
Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.
Journal: International journal of cancer
Published: November 20, 2014
Plasma membrane-associated sialidase confers cancer initiation, promotion and progression.
Journal: Advances in experimental medicine and biology
Published: November 20, 2014
Cancer-selective induction of apoptosis by leczyme.
Journal: Frontiers in oncology
Published: March 28, 2014
Leczyme: a new candidate drug for cancer therapy.
Journal: BioMed research international
Published: January 31, 2014
Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.
Journal: International journal of oncology
Published: August 01, 2013
Last Updated: 09/26/2026